1-(tert-Butyl) 2-methyl (2R,4S)-4-hydroxy-2-methylpyrrolidine-1,2-dicarboxylate

Catalog No. :
ACXIQR569
CAS No. :
1975992-77-8
Molecular Formula :
C12H21NO5
Molecular Weight :
259.30

IUPAC Name:1-(tert-butyl) 2-methyl (2R,4S)-4-hydroxy-2-methylpyrrolidine-1,2-dicarboxylate

1-(tert-Butyl) 2-methyl (2R,4S)-4-hydroxy-2-methylpyrrolidine-1,2-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$163.00Login to see priceInquiryInquiry
100mg98%$276.00Login to see priceInquiryInquiry
250mg98%$468.00Login to see priceInquiryInquiry
1g98%$1311.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butyl) 2-methyl (2R,4S)-4-hydroxy-2-methylpyrrolidine-1,2-dicarboxylate
IUPAC Name1-(tert-butyl) 2-methyl (2R,4S)-4-hydroxy-2-methylpyrrolidine-1,2-dicarboxylate
MDL No.MFCD30829719
Molecular FormulaC12H21NO5
Molecular Weight259.30
SMILESO=C(OC(C)(C)C)N1[C@](C)(C[C@@H](C1)O)C(OC)=O
InChI KeyCTBPJCTYTFHHRY-QPUJVOFHSA-N
Synonym1,2-Pyrrolidinedicarboxylic acid, 4-hydroxy-2-methyl-, 1-(1,1-dimethylethyl) 2-methyl ester, (2R,4S)-
CAS No.1975992-77-8
PubChem CID130305468

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACXIQR569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXIQR569 route product structure diagram
    ACXIQR5691975992-77-8
Inquiry

2. ACXIQR569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXIQR569 route product structure diagram
    ACXIQR5691975992-77-8
Inquiry

Comments (0)